Structural Heart Devices Market Size, Share, Growth and Value 2032

Structural Heart Devices Market

Structural Heart Devices Market By Product Type (Heart Valve Devices, Occluders and Delivery Systems, Annuloplasty Rings, and Accessories), By Indication (Atrial Septal Defect (ASD), Patent Foramen Ovale (PFO), Ventricular Septal Defect (VSD), and Aortic Valve Stenosis), and by End-User (Hospitals, Ambulatory Surgical Centers, and others): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2024-2032

Category: Medical Device Report Format : PDF Pages: 208 Report Code: ZMR-3755 Published Date: Dec-2024 Status : Published
Market Size in 2023 Market Forecast in 2032 CAGR (in %) Base Year
USD 14.83 Billion USD 34.20 Billion 9.73% 2023

Structural Heart Devices Market

Structural Heart Devices Industry Prospective:

The global Structural Heart Devices market size accrued earnings worth approximately USD 14.83 Billion in 2023 and is predicted to gain revenue of about USD 34.20 Billion by 2032, is set to record a CAGR of nearly 9.73% over the period from 2024 to 2032.

The study includes the drivers and restraints of the Structural Heart Devices Market along with the impact they have on the demand over the forecast time period. Additionally, the report includes the study of opportunities available in the Structural Heart Devices Market on a global level.

Global Structural Heart Devices MarketRequest Free Sample

Structural Heart Devices Market: Overview

Structural heart devices are used to maintain the normal structure of a human heart. Due to the various congenital defects and cardiovascular infections, heart muscles lose their shape. This, in turn, affects the normal functioning of the heart. Common heart structural diseases include atrial septal defects, patient foramen ovale, Paravalvular leak, etc. These devices can be placed through minimally invasive procedures, whereas a few cases need open heart surgery. Minimally invasive surgeries have reduced the risk and decreased the recovery time.

One of the major factors likely to drive the structural heart devices market globally in the future is the constant increase in the prevalence of congenital heart defects. As per the Centers for Disease Control and Prevention 2018 report, there were around 40,000 infants diagnosed with congenital heart defects in the U.S. Moreover, there is a constant increase in the demand of minimally invasive surgeries coupled with an increased recovery rate.

Furthermore, substantial increase related to technological advancements and research and development activities has resulted in the introduction of innovative products, thereby promoting the structural heart devices market growth in the future. However, the high cost of these devices and the enforcement of stringent legislation governing the approval of new devices might hamper the structural heart devices market over the estimated time span.

Global Structural Heart Devices MarketRequest Free Sample

In order to give the users of this report a comprehensive view of the Structural Heart Devices Market, we have included a competitive landscape and an analysis of Porter’s Five Forces model of the market. The study encompasses a market attractiveness analysis, wherein all the segments are benchmarked based on their market size, growth rate, and general attractiveness.

The report provides company market share analysis to give a broader overview of the key market players. In addition, the report also covers key strategic developments in the market, including acquisitions & mergers, new product launch, agreements, partnerships, collaborations & joint ventures, research & development, and regional expansion of major participants involved in the market on a global and regional basis.

Structural Heart Devices Market: Segmentation

The global structural heart devices market is classified on the basis of product type, indication, and end-user.

By product type, the structural heart devices market includes heart valve devices, occluders, and delivery systems, annuloplasty rings, and accessories. Heart valve devices are expected to dominate the structural heart devices market in the upcoming years.

By indication, the structural heart devices market is segmented into atrial septal defect (ASD), patent foramen ovale (PFO), ventricular septal defect (VSD), and aortic valve stenosis.

By end-user, the structural heart devices market is segmented into hospitals, ambulatory surgical centers, and others.

Structural Heart Devices Market: Report Scope

Report Attributes Report Details
Report Name Structural Heart Devices Market
Market Size in 2023 USD 14.83 Billion
Market Forecast in 2032 USD 34.20 Billion
Growth Rate CAGR of 9.73%
Number of Pages 208
Key Companies Covered Abbott Laboratories, Medtronic Plc., Endologix Inc., LivaNova Plc., Boston Scientific Corporation, CryoLife Inc., Cook Group Incorporated, Edwards Lifesciences Corporation, and W. L. Gore & Associates, Inc., among others
Segments Covered By product type, By indication, By end-user and By Region
Regions Covered North America, Europe, Asia Pacific (APAC), Latin America, Middle East, and Africa (MEA)
Base Year 2023
Historical Year 2018 to 2022
Forecast Year 2024 - 2032
Customization Scope Avail customized purchase options to meet your exact research needs. Request For Customization

Structural Heart Devices Market: Regional Analysis

By region, the global structural heart devices market includes North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. North America is expected to lead the structural heart devices market globally over the forecast time period, followed by Europe. The Asia Pacific region is projected to be the fastest growing region over the estimated timeframe, owing to the significant contributions made by developing economies, such as India and China. The Latin American and the Middle Eastern and African markets are anticipated to grow moderately in the future.

Structural Heart Devices Market: Competitive Analysis

The global structural heart devices market is dominated by players like:

  • Abbott Laboratories
  • Medtronic Plc
  • Endologix Inc
  • LivaNova Plc
  • Boston Scientific Corporation
  • CryoLife Inc
  • Cook Group Incorporated
  • Edwards Lifesciences Corporation
  • W. L. Gore & Associates, Inc

This report segments the global structural heart devices market into:

Global Structural Heart Devices Market: Product Type Analysis

  • Heart Valve Devices
  • Occluders and Delivery Systems
  • Annuloplasty Rings
  • Accessories

Global Structural Heart Devices Market: Indication Analysis

  • Atrial Septal Defect (ASD)
  • Patent Foramen Ovale (PFO)
  • Ventricular Septal Defect (VSD)
  • Aortic Valve Stenosis

Global Structural Heart Devices Market: End-User Analysis

  • Hospitals
  • Ambulatory Surgical Centers
  • Others

Global Structural Heart Devices Market: Regional Analysis

  • North America
    • The U.S.
  • Europe
    • UK
    • France
    • Germany
  • Asia Pacific
    • China
    • Japan
    • India
  • Latin America
    • Brazil
  • Middle East and Africa

Table Of Content

Methodology

FrequentlyAsked Questions

Structural heart devices are medical devices that are employed to address abnormalities or defects in the heart's structure, which encompasses the heart valves, walls, and compartments. These devices are frequently employed as an alternative to open-heart surgery in order to address structural deficiencies, increase blood flow, and improve overall cardiac function.

The structural heart devices market is anticipated to experience substantial growth as a result of the increasing prevalence of heart-related disorders, the development of minimally invasive technologies, and the growing demand for enhanced cardiac care solutions.

The global Structural Heart Devices market size accrued earnings worth approximately USD 14.83 Billion in 2023 and is predicted to gain revenue of about USD 34.20 Billion by 2032.

The global Structural Heart Devices market is set to record a CAGR of nearly 9.73% over the period from 2024 to 2032.

By region, the global structural heart devices market includes North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. North America is expected to lead the structural heart devices market globally over the forecast time period, followed by Europe.

Some major market players of the global structural heart devices include Abbott Laboratories, Medtronic Plc., Endologix Inc., LivaNova Plc., Boston Scientific Corporation, CryoLife Inc., Cook Group Incorporated, Edwards Lifesciences Corporation, and W. L. Gore & Associates, Inc., among others.

Choose License Type

  • zion payment modes

HappyClients

Office Address

Contact Us

Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651

Asia Pacific Office

3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008

Contact #

US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com

We Are On Social

twitter

Industry Press Release

We Accept

We have secured system to process your transaction.

  • payment methods

Business Hours

Our support available to help you 24 hours a day, five days a week.

Monday - Friday: 9AM - 6PM

Saturday - Sunday: Closed